Use of a bioactive scaffold for the repair of bone defects in a novel reproducible vertebral body defect model

Bone

Volumn 47, Issue 2, 2010, Pages 197-204

  Liang, Haixiang ^a   Wang, Kun ^b   Shimer, Adam L ^a   Li, Xudong ^a   Balian, Gary ^a   Shen, Francis H ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c NONE   (United States)

Author keywords

Animal model; Bone defect; Bone morphogenic protein; Spine; Tissue engineering

Indexed keywords

BIOMATERIAL; MATRIGEL; MICROSPHERE; POLYGLACTIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; DRUG COMBINATION; LACTIC ACID; LAMININ; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE GROWTH; BONE REMODELING; BONE TISSUE; CONTROLLED STUDY; GROWTH INHIBITION; HISTOLOGY; MALE; NONHUMAN; OSSIFICATION; RAT; REPRODUCIBILITY; TISSUE ENGINEERING; TREATMENT RESPONSE; VERTEBRA BODY; ANIMAL; BONE DEVELOPMENT; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; FISCHER 344 RAT; METABOLISM; PATHOLOGY; RADIOGRAPHY; SCANNING ELECTRON MICROSCOPY; SPINE; TISSUE SCAFFOLD; WOUND HEALING;

ANIMALS; BIOCOMPATIBLE MATERIALS; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; LACTIC ACID; LAMININ; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; OSTEOGENESIS; POLYGLYCOLIC ACID; PROTEOGLYCANS; RATS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS; SPINE; TISSUE SCAFFOLDS; TOMOGRAPHY, X-RAY COMPUTED; WOUND HEALING;

EID: 77955982214     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.05.023     Document Type: Article

References (36)

1. Kim D.H., Vaccaro A.R. Osteoporotic compression fractures of the spine; current options and considerations for treatment. Spine J. 2006, 6:479-487.
2. Horner E.A., Kirkham J., Wood D., Curran S.J., Smith M., Thomson B., Yang X.B. Long bone defect models for tissue engineering applications: criteria for choice. Tissue Eng. B Rev. 2009.
3. Shirasu N., Ueno T., Hirata Y., Hirata A., Kagawa T., Kanou M., Sawaki M., Wakimoto M., Ota A., Imura H., Matsumura T., Yamada T., Yamachika E., Sano K. Bone formation in a rat calvarial defect model after transplanting autogenous bone marrow with beta-tricalcium phosphate. Acta Histochem. 2009.
4. Cestari T.M., Granjeiro J.M., de Assis G.F., Garlet G.P., Taga R. Bone repair and augmentation using block of sintered bovine-derived anorganic bone graft in cranial bone defect model. Clin. Oral Implants Res. 2009, 20:340-350.
5. Reichert J.C., Saifzadeh S., Wullschleger M.E., Epari D.R., Schutz M.A., Duda G.N., Schell H., van G.M., Redl H., Hutmacher D.W. The challenge of establishing preclinical models for segmental bone defect research. Biomaterials 2009, 30:2149-2163.
6. Phillips F.M., Turner A.S., Seim H.B., MacLeay J., Toth C.A., Pierce A.R., Wheeler D.L. In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model. Spine J. 2006, 6:500-506.
7. Kobayashi H., Fujishiro T., Belkoff S.M., Kobayashi N., Turner A.S., Seim H.B., Zitelli J., Hawkins M., Bauer T.W. Long-term evaluation of a calcium phosphate bone cement with carboxymethyl cellulose in a vertebral defect model. J. Biomed. Mater. Res. A 2008.
8. Fujishiro T., Bauer T.W., Kobayashi N., Kobayashi H., Sunwoo M.H., Seim H.B., Turner A.S. Histological evaluation of an impacted bone graft substitute composed of a combination of mineralized and demineralized allograft in a sheep vertebral bone defect. J. Biomed. Mater. Res. A 2007, 82:538-544.
9. Turner T.M., Urban R.M., Singh K., Hall D.J., Renner S.M., Lim T.H., Tomlinson M.J., An H.S. Vertebroplasty comparing injectable calcium phosphate cement compared with polymethylmethacrylate in a unique canine vertebral body large defect model. Spine J. 2008, 8:482-487.
10. Adachi A., Kaminou T., Ogawa T., Kawai T., Takaki Y., Sugiura K., Ohuchi Y., Hashimoto M. Heat distribution in the spinal canal during radiofrequency ablation for vertebral lesions: study in swine. Radiology 2008, 247:374-380.
11. Oner F.C., van der Rijt R.R., Ramos L.M., Dhert W.J., Verbout A.J. Changes in the disc space after fractures of the thoracolumbar spine. J. Bone Joint Surg. Br. 1998, 80:833-839.
12. Oner F.C., van Gils A.P., Dhert W.J., Verbout A.J. MRI findings of thoracolumbar spine fractures: a categorisation based on MRI examinations of 100 fractures. Skeletal Radiol. 1999, 28:433-443.
13. Yamamoto M., Takahashi Y., Tabata Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 2003, 24:4375-4383.
14. Yamamoto M., Tabata Y., Ikada Y. Ectopic bone formation induced by biodegradable hydrogels incorporating bone morphogenetic protein. J. Biomater. Sci. Polym. Ed. 1998, 9:439-458.
15. Maeda H., Sano A., Fujioka K. Controlled release of rhBMP-2 from collagen minipellet and the relationship between release profile and ectopic bone formation. Int. J. Pharm. 2004, 275:109-122.
16. Yoshida K., Bessho K., Fujimura K., Kusumoto K., Ogawa Y., Tani Y., Iizuka T. Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study. J. Craniomaxillofac. Surg. 1998, 26:112-115.
17. Khan S.N., Lane J.M. The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications. Expert Opin. Biol. Ther. 2004, 4:741-748.
18. McKay W.F., Peckham S.M., Badura J.M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int. Orthop. 2007, 31:729-734.
19. Oldham J.B., Lu L., Zhu X., Porter B.D., Hefferan T.E., Larson D.R., Currier B.L., Mikos A.G., Yaszemski M.J. Biological activity of rhBMP-2 released from PLGA microspheres. J. Biomech. Eng. 2000, 122:289-292.
20. Shen H., Hu X., Yang F., Bei J., Wang S. The bioactivity of rhBMP-2 immobilized poly(lactide-co-glycolide) scaffolds. Biomaterials 2009, 30:3150-3157.
21. Boden S.D., Schimandle J.H., Hutton W.C. An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. Spine 1995, 20:412-420.
22. Sundaramurthy S., Mao J.J. Modulation of endochondral development of the distal femoral condyle by mechanical loading. J. Orthop. Res. 2006, 24:229-241.
23. Haynesworth S.E., Goshima J., Goldberg V.M., Caplan A.I. Characterization of cells with osteogenic potential from human marrow. Bone 1992, 13:81-88.
24. Breitbart A.S., Grande D.A., Kessler R., Ryaby J.T., Fitzsimmons R.J., Grant R.T. Tissue engineered bone repair of calvarial defects using cultured periosteal cells. Plast. Reconstr. Surg. 1998, 101:567-574.
25. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., Robey P.G. Circulating skeletal stem cells. J. Cell Biol. 2001, 153:1133-1140.
26. Ford J.L., Robinson D.E., Scammell B.E. Endochondral ossification in fracture callus during long bone repair: the localisation of 'cavity-lining cells' within the cartilage. J. Orthop. Res. 2004, 22:368-375.
27. Borden M., Attawia M., Laurencin C.T. The sintered microsphere matrix for bone tissue engineering: in vitro osteoconductivity studies. J. Biomed. Mater. Res. 2002, 61:421-429.
28. Borden M., Attawia M., Khan Y., El-Amin S.F., Laurencin C.T. Tissue-engineered bone formation in vivo using a novel sintered polymeric microsphere matrix. J. Bone Joint Surg. Br. 2004, 86:1200-1208.
29. Borden M., El-Amin S.F., Attawia M., Laurencin C.T. Structural and human cellular assessment of a novel microsphere-based tissue engineered scaffold for bone repair. Biomaterials 2003, 24:597-609.
30. Shen F.H., Zeng Q., Lv Q., Choi L., Balian G., Li X., Laurencin C.T. Osteogenic differentiation of adipose-derived stromal cells treated with GDF-5 cultured on a novel three-dimensional sintered microsphere matrix. Spine J. 2006, 6:615-623.
31. Kempen D.H., Lu L., Hefferan T.E., Creemers L.B., Maran A., Classic K.L., Dhert W.J., Yaszemski M.J. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008, 29:3245-3252.
32. Chung Y.I., Ahn K.M., Jeon S.H., Lee S.Y., Lee J.H., Tae G. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J. Control. Release 2007, 121:91-99.
33. Hong L., Tabata Y., Yamamoto M., Miyamoto S., Yamada K., Hashimoto N., Ikada Y. Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution. J. Biomater. Sci. Polym. Ed. 1998, 9:1001-1014.
34. Baumgart R., Betz A., Kessler S., Kettler M., Schweiberer L. Possibilities in the reconstruction of bone defects. Orthopade 1994, 23:396-403.
35. Aerssens J., Boonen S., Lowet G., Dequeker J. Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology 1998, 139:663-670.
36. Egermann M., Goldhahn J., Schneider E. Animal models for fracture treatment in osteoporosis. Osteoporos. Int. 2005, 16(Suppl 2):S129-S138.